癌变·畸变·突变 ›› 2000, Vol. 12 ›› Issue (4): 223-226.doi: 10.3969/j.issn.1004-616x.2000.04.009

• 论著 • 上一篇    下一篇

环磷酰胺和异环磷酰胺致突变作用比较研究

施畅;马华智;廖明阳   

  1. 军事医学科学院毒物药物研究所,北京100850
  • 收稿日期:1999-09-04 修回日期:2000-03-30 出版日期:2000-10-30 发布日期:2000-10-30

A COMPARARIVE STUDY oN THE MUTAGENICITY OF CYCLOPHOSPHAMIDE AND IFOSFAM IDE

SHI Chang,MA Hua—zhi.LIAO Ming—yang   

  1. Institute ofPharmacology and Toxicology,TheAcademy ofMilitary.Medical Sciences,BeOing 100850,China
  • Received:1999-09-04 Revised:2000-03-30 Online:2000-10-30 Published:2000-10-30

摘要: 目的与方法:本文通过Am髂试验和SOS显色试验比较了环磷酰胺(cP)与异 磷酰胺(IFO)的致突变作用。结果:(和[FO在有s9活化的情况下.均可显著增加碱基置换型检测菌株TA100的回变菌落数.并呈现明显的剂量——效应关系,但两药的作用强度不同.同等剂量时IFO诱发的回变菌落数均少于CP. 0∞ 皿的剂量下CP诱发呵变苗落数为空白对照的12倍以上。IFO仅为空白对照的5倍左右;在无s9活化时两药对TA100菌株菌落同变均无影响,而对移码荚变型捡删菌株TA97、TA98、TA102,两药无论有无s9活化均对菌落回变无显著影响。SOS显色试验则表明.即使在有S9活化条件下,两药对大肠杆菌PQ35、PQ37菌株SOS修复系统均无诱导性。结论:cP和IF()都是通过引起DNA碱基置换诱发突变. 且等剂量条件下1FO的致突变作用弱于CP.提示对生产和操作^兔应采取必要的防护措施。

关键词: 环磷酰胺:异环磷酰胺, 致突变, Ames试验, SOS显色试验

Abstract: Purpose and Methods:The mutagenielty of Cyclophosphamide(CP)and Ifosfamide(IFO)was stud— led using An1es test and SOS chromotest.Results·In Ames test both CP and IFO were found negative results on strain TA100 without metabolic activation system (S9一mix)but positive in the presence of S9一mix,showing a significant dose— dfect relationship.The mutageniclty induced by both drugs were of different degree The amount of rev~'se mutation induced by IFO was Iess than that of CP at the same dose Ieve[.At 1 0O()ug/plate dose 1evel-the amount of reverse mutation induced by CP and IF0 was twelve times and five times m0re than that of the control respectively.However,negative results were observed on strain TA97、TA98 and TA102 (without or with s9 mix)for both drugs But SOS chromotest indicated that neither CP and IFO had inducti。n SOS repair system in E Coli strain PQ35、PQ37 with or without 89 mix.Conchmion:We c0nduded that the mutagenicity of CP and IF0 was resulted from base substitution induced by themselves,and CP showed stf0ngef mutagenicity than IFO. Thus protection for workers producing or operating CP and IFO against their genotoxicity was necessary.

Key words: cyclophosphamide, ifosfamide, mutagenicity, Ames test, SOS chromotest

中图分类号: